- PhaseBio Pharmaceuticals (NASDAQ:PHAS) has closed its public offering of ~4.1M common shares at $12 per share yielding gross proceeds of $49.5M.
- Shares are down 2% after hours.
PhaseBio closes $49.5M capital raise
Recommended For You
About PHASQ Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
PHASQ | - | - |
PhaseBio Pharmaceuticals, Inc. |